- About AAAP
- Member Center
- Meetings and Events
- Education and Training
- Buprenorphine
Scottsdale, Arizona, USA
AAAP will be holding a 2010 Summer Review Course in conjunction with the 72nd Annual Meeting for The College on Problems of Drug Dependence (CPDD).
For more information, please scroll down. Questions? Email reviewcourse@aaap.org.
The 2010 AAAP Addiction Board Review Course at CPDD: A Clinical Review of Substance Use Disorders continues to meet the academic and scientific standards set by AAAP over the past decade. The course is an excellent preparation for the ABPN examinations for subspecialty certification and recertification in addiction psychiatry. Past participants have recommended that this course be required for general psychiatry and PGY-V residents, as well as periodically for all academic and treatment personnel to stay updated on the most recent trends in the addiction field.
Registration by fax, mail and email for this course is now CLOSED. Online registration for this course is not available.
After June 1st: You may register on-site only. If you plan on attending, please complete and bring the registration form (below) to the course registration desk in Arizona.
The registration fee includes one syllabus (bound book) that contains slides with accompanying text, bibliographical information and any sample exam questions.
Resident/Medical Student ........................ $200
Department of Psychiatry, Yale University of Medicine and Connecticut VA Health Care System
Dr. Sevarino is Assistant Professor of Psychiatry at the VA Medical Center in Newington, Connecticut, and Chief Psychiatric Consultant, Gaylord Hospital, Wallingford, Connecticut.
- General Concepts
- Psychosocial Treatment of Addictions
- Cocaine
- Alcohol
- Nicotine
- Opiates
At the conclusion of this course participants should be able to:
- Discuss new advances in the pharmacotherapy and psychotherapy of alcohol, cocaine, opioid and nicotine addictive disorders.
- Discuss the epidemiology of substance use disorders and their co-occurrence with other mental disorders.
- Discuss the role of genetics in the risk for developing alcohol and drug use disorders.
- Identify the major neurobiological pathways involved in the addictive disorders.
- Identify the molecular mechanisms that are altered following drug and alcohol use.
- Identify appropriate treatment to most effectively address patient's substance use and mental health disorders and implement strategies for their use
- Improve understanding and working knowledge of substance abuse treatment guidelines and put them use in your clinical practice
The Medical University of South Carolina designates this educational activity for a maximum of 6 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.
This activity has been designed in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Medical University of South Carolina and the American Academy of Addiction Psychiatry. The Medical University of South Carolina is accredited by the ACCME to provide continuing medical education for physicians.
In accordance with ACCME Essentials and Standards, anyone involved in planning or presenting this educational activity will be required to disclose any relevant financial relationships with commercial interests in the healthcare industry. This information will be made available to participants at the beginning of the activity.
Speakers who incorporate information about off-label or investigational use of drugs or devices will be asked to disclose that information at the beginning of their presentation.
For more information or to register for the exam, contact:
American Board of Psychiatry and Neurology, Inc.
www.abpn.com